|
HRP20160082T1
(hr)
|
2006-09-29 |
2016-02-26 |
Oncomed Pharmaceuticals, Inc. |
Sastavi i postupci za dijagnosticiranje i lijeäśenje raka
|
|
RU2010120674A
(ru)
*
|
2007-10-22 |
2011-11-27 |
Шеринг Корпорейшн (US) |
Полностью человеческие анти-vegf-антитела и способы их применения
|
|
KR101093717B1
(ko)
*
|
2008-11-26 |
2011-12-19 |
한국생명공학연구원 |
Ｖｅｇｆ―특이적인 인간항체
|
|
WO2010124009A2
(en)
*
|
2009-04-21 |
2010-10-28 |
Schering Corporation |
Fully human anti-vegf antibodies and methods of using
|
|
US9067986B2
(en)
*
|
2009-04-27 |
2015-06-30 |
Oncomed Pharmaceuticals, Inc. |
Method for making heteromultimeric molecules
|
|
CN102002104A
(zh)
*
|
2009-08-28 |
2011-04-06 |
江苏先声药物研究有限公司 |
一种抗vegf的单克隆抗体及含有该抗体的药物组合物
|
|
EP3485908B1
(en)
|
2009-10-16 |
2021-08-18 |
Mereo BioPharma 5, Inc. |
Therapeutic combination and use of dll4 antagonist antibodies and anti-hypertensive agents
|
|
CN102167740B
(zh)
*
|
2010-02-25 |
2014-06-04 |
上海百迈博制药有限公司 |
一种全人源抗vegf单克隆抗体、其制备方法及用途
|
|
US20120225081A1
(en)
*
|
2010-09-03 |
2012-09-06 |
Boehringer Ingelheim International Gmbh |
Vegf-binding molecules
|
|
US8551479B2
(en)
|
2010-09-10 |
2013-10-08 |
Oncomed Pharmaceuticals, Inc. |
Methods for treating melanoma
|
|
US9527925B2
(en)
|
2011-04-01 |
2016-12-27 |
Boehringer Ingelheim International Gmbh |
Bispecific binding molecules binding to VEGF and ANG2
|
|
CN102757495A
(zh)
*
|
2011-04-26 |
2012-10-31 |
中国人民解放军第二军医大学 |
一种全人源抗vegf抗体、其制备方法及用途
|
|
CN102875676B
(zh)
*
|
2011-07-13 |
2014-11-05 |
无锡天演生物技术有限公司 |
全人源抗人vegf单抗分子及其应用
|
|
TWI583699B
(zh)
|
2011-09-23 |
2017-05-21 |
安可美德藥物股份有限公司 |
Ｖｅｇｆ／ｄｌｌ４結合劑類及彼等之用途
|
|
CA2889638A1
(en)
|
2012-10-31 |
2014-05-08 |
Oncomed Pharmaceuticals, Inc. |
Methods and monitoring of treatment with a dll4 antagonist
|
|
WO2014104406A1
(ja)
*
|
2012-12-27 |
2014-07-03 |
学校法人慶應義塾 |
骨粗鬆症治療剤及び治療剤のスクリーニング方法
|
|
JP2016530244A
(ja)
*
|
2013-12-31 |
2016-09-29 |
ディベロップメント センター フォー バイオテクノロジーＤｅｖｅｌｏｐｍｅｎｔ Ｃｅｎｔｅｒ Ｆｏｒ Ｂｉｏｔｅｃｈｎｏｌｏｇｙ |
抗ｖｅｇｆ抗体及びその使用
|
|
WO2015200905A2
(en)
|
2014-06-28 |
2015-12-30 |
Oligasis, Llc |
Dual pdgf/vegf antagonists
|
|
EP3212233B1
(en)
|
2014-10-31 |
2020-06-24 |
Oncomed Pharmaceuticals, Inc. |
Combination therapy for treatment of disease
|
|
US11339213B2
(en)
|
2015-09-23 |
2022-05-24 |
Mereo Biopharma 5, Inc. |
Methods and compositions for treatment of cancer
|
|
US10640772B2
(en)
|
2015-11-30 |
2020-05-05 |
Nissan Chemical Industries, Ltd. |
DNA aptamers binding to molecular targeted agents and detection method of molecular targeted medicine using the same
|
|
IL290457B2
(en)
|
2015-12-30 |
2025-02-01 |
Kodiak Sciences Inc |
Antibodies and their conjugates
|
|
JP6949106B2
(ja)
*
|
2016-08-23 |
2021-10-13 |
メディミューン リミテッド |
抗ｖｅｇｆ−ａ抗体ならびにそれらの使用
|
|
WO2019129677A1
(en)
|
2017-12-29 |
2019-07-04 |
F. Hoffmann-La Roche Ag |
Anti-vegf antibodies and methods of use
|
|
CA3092588A1
(en)
|
2018-03-02 |
2019-09-06 |
Kodiak Sciences Inc. |
Il-6 antibodies and fusion constructs and conjugates thereof
|
|
WO2020127864A1
(en)
*
|
2018-12-21 |
2020-06-25 |
F. Hoffmann-La Roche Ag |
Method for improving inhibition of vegf-binding to vegf-r1 of an anti-vegf antibody
|
|
WO2021013064A1
(zh)
*
|
2019-07-19 |
2021-01-28 |
神州细胞工程有限公司 |
一种人源化vegfr2抗体及其应用
|
|
CA3157509A1
(en)
|
2019-10-10 |
2021-04-15 |
Kodiak Sciences Inc. |
Methods of treating an eye disorder
|
|
WO2023109904A1
(zh)
*
|
2021-12-16 |
2023-06-22 |
石药集团中奇制药技术（石家庄）有限公司 |
多西他赛白蛋白组合物与vegf抑制剂或vegfr抑制剂的组合及用途
|
|
KR20240164784A
(ko)
*
|
2022-03-30 |
2024-11-20 |
시 안 오리맵 바이오테크놀로지 컴퍼니 리미티드 |
항-psma 항체, 이의 변이체 및 이의 용도
|
|
CN115850470B
(zh)
*
|
2022-12-12 |
2023-07-07 |
三门峡市眼科医院 |
Vegf抗体及其应用
|